ImmunityBio (IBRX) Ownership - Who Owns ImmunityBio?

2,498 Followers

ImmunityBio (IBRX) Ownership Overview

62.91% Insiders

3.96% Mutual Funds

2.62% Other Institutional Investors

6.31% ETFs

24.20% Public Companies and Individual Investors

The ownership structure of ImmunityBio (IBRX) stock is a mix of institutional, retail, and individual investors. Approximately 12.89% of the company’s stock is owned by Institutional Investors, 62.91% is owned by Insiders, and 24.20% is owned by Public Companies and Individual Investors.

The ownership structure of ImmunityBio (IBRX) stock is a mix of institutional, retail, and individual investors. Approximately 6.58% of the company’s stock is owned by Institutional Investors, 62.91% is owned by Insiders, and 6.31% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Apr 02, 2026	Shiong Patrick Soon	xxxxxxxxxxxxx	$24967750

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Clough Capital Partners L P	xxxxxxxxxxxxx	$721294
Mar 31, 2024	Stilwell Value Llc	xxxxxxxxxxxxx	$613600
Mar 31, 2024	Woodline Partners Lp	xxxxxxxxxxxxx	$26441144
Mar 31, 2024	Goalvest Advisory Llc	xxxxxxxxxxxxx	$3835

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	654,612,336	Insider	62.50%	4,529,917,365
	30,997,069	Institution	2.96%	214,499,717
	27,688,648	Institution	2.64%	191,605,444
	15,703,270	Institution	1.50%	108,666,628
	12,155,623	Institution	1.16%	84,116,911
	3,451,428	Institution	0.33%	23,883,882
Michael Rockefeller	3,447,346	Institution	0.33%	23,855,634
	3,144,913	Institution	0.30%	21,762,798
	2,827,788	Insider	0.27%	19,568,293
	1,747,009	Institution	0.17%	12,089,302

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
27,688,648	Institution	2.64%	191,605,444
3,451,428	Institution	0.33%	23,883,882
3,144,913	Institution	0.30%	21,762,798
1,747,009	Institution	0.17%	12,089,302
995,597	Institution	0.10%	6,889,531
886,389	Institution	0.08%	6,133,812
881,772	Institution	0.08%	6,101,862
465,000	Institution	0.04%	3,217,800
395,431	Institution	0.04%	2,736,383
233,398	Institution	0.02%	1,615,114

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	11,480,900	Institution	1.10%	81,514,390
SPDR S&P BIOTECH ETF	11,242,742	Institution	1.07%	81,959,589
Vanguard Small-Cap ETF	8,292,147	Institution	0.79%	58,874,244
iShares Russell 2000 ETF	6,901,875	Institution	0.66%	47,760,975
Vanguard Small-Cap Growth ETF	4,665,097	Institution	0.45%	33,122,189
Vanguard Extended Market ETF	3,447,221	Institution	0.33%	24,475,269
iShares Biotechnology ETF	2,520,022	Institution	0.24%	17,438,552
iShares Russell 2000 Growth ETF	2,004,160	Institution	0.19%	13,868,787
Vanguard Russell 2000 ETF	1,491,806	Institution	0.14%	10,591,823
Schwab U.S. Small-Cap ETF	1,468,624	Institution	0.14%	10,706,269

FAQ

Who Owns Immunitybio Inc (IBRX)?

According to the latest TipRanks data, approximately 2.62% of the company's stock is held by institutional investors, 62.91% is held by insiders, and 24.20% is held by retail investors.

What percentage of Immunitybio Inc (IBRX) stock is held by institutional investors?

According to the latest TipRanks data, approximately 2.62% of Immunitybio Inc (IBRX) stock is held by institutional investors.

What percentage of Immunitybio Inc (IBRX) stock is held by retail investors?

According to the latest TipRanks data, approximately 24.20% of Immunitybio Inc (IBRX) stock is held by retail investors.

Who owns the most shares of Immunitybio Inc (IBRX)?

Shiong Patrick Soon owns the most shares of Immunitybio Inc (IBRX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.